Neuroprotective effects of riluzole in Alzheimer's disease: A comprehensive review
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neuroprotective effects of riluzole in Alzheimer's disease: A comprehensive review
Authors
Keywords
-
Journal
FUNDAMENTAL & CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-09-27
DOI
10.1111/fcp.12955
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Effective Components, Core Targets, and Key Pathways of Ginseng against Alzheimer’s Disease
- (2023) Yabo Wang et al. Evidence-based Complementary and Alternative Medicine
- In-silico docking and molecular dynamic introspective study of multiple targets of AChE with Rivastigmine and NMDA receptors with Riluzole for Alzheimer’s disease
- (2023) Narendar Chintha et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Sterubin protects against chemically-induced Alzheimer’s disease by reducing biomarkers of inflammation- IL-6/ IL-β/ TNF-α and oxidative stress- SOD/MDA in rats
- (2023) Imran Kazmi et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- A local circuit-basis for spatial navigation and memory processes in hippocampal area CA1
- (2023) Tristan Geiller et al. CURRENT OPINION IN NEUROBIOLOGY
- Amyloidosis in Alzheimer’s Disease: Pathogeny, Etiology, and Related Therapeutic Directions
- (2022) Chen Ma et al. MOLECULES
- Riluzole restores memory and brain energy metabolism in AβPP-PS1 mouse model of Alzheimer's disease
- (2022) Kamal Saba et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Combined Treatment with Bojungikgi-Tang and Riluzole Regulates Muscle Metabolism and Dysfunction in the hSOD1G93A Mouse Model
- (2022) Mudan Cai et al. Antioxidants
- Riluzole and novel naphthalenyl substituted aminothiazole derivatives prevent acute neural excitotoxic injury in a rat model of temporal lobe epilepsy
- (2022) Thomas Kyllo et al. NEUROPHARMACOLOGY
- Inclusion of the C-Terminal Domain in the β-Sheet Core of Heparin-Fibrillized Three-Repeat Tau Protein Revealed by Solid-State Nuclear Magnetic Resonance Spectroscopy
- (2021) Aurelio J. Dregni et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer’s disease
- (2021) Dawn C Matthews et al. BRAIN
- Riluzole: a therapeutic strategy in Alzheimer’s disease by targeting the WNT/β-catenin pathway
- (2020) Alexandre Vallée et al. Aging-US
- Riluzole ameliorates soluble Aβ1–42-induced impairments in spatial memory by modulating the glutamatergic/GABAergic balance in the dentate gyrus
- (2020) Yang Yang et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Riluzole attenuates glutamatergic tone and cognitive decline in AβPP/PS1 mice
- (2020) Kevin N. Hascup et al. JOURNAL OF NEUROCHEMISTRY
- Hippocampal hyperglutamatergic signaling matters: Early targeting glutamate neurotransmission as a preventive strategy in Alzheimer's disease
- (2020) Natalia V. Gulyaeva JOURNAL OF NEUROCHEMISTRY
- Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics
- (2020) Amna Akhtar et al. JOURNAL OF CONTROLLED RELEASE
- Stabilized amorphous state of riluzole by immersion-rotavapor method with synthesized mesoporous SBA-15 carrier to augment in-vitro dissolution
- (2020) Ravish J. Patel et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Treatment with the glutamate modulator riluzole prevents early life stress-induced cognitive deficits and impairments in synaptic plasticity in APPswe/PS1dE9 mice
- (2019) Sylvie L. Lesuis et al. NEUROPHARMACOLOGY
- A Pharmacokinetic Bioequivalence Study Comparing Sublingual Riluzole (BHV‐0223) and Oral Tablet Formulation of Riluzole in Healthy Volunteers
- (2019) Irfan Qureshi et al. Clinical Pharmacology in Drug Development
- A Sequential Ensemble Model For Communicable Disease Forecasting
- (2019) Nashreen Sultana et al. Current Bioinformatics
- N-methyl-D-aspartate receptor–mediated calcium influx connects amyloid-β oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease
- (2018) Erin J. Kodis et al. Alzheimers & Dementia
- Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
- (2018) Melanie D. Sweeney et al. Nature Reviews Neurology
- Diet-induced insulin resistance elevates hippocampal glutamate as well as VGLUT1 and GFAP expression in AβPP/PS1 mice
- (2018) Erin R. Hascup et al. JOURNAL OF NEUROCHEMISTRY
- Combined Memantine and Donepezil Treatment Improves Behavioral and Psychological Symptoms of Dementia-Like Behaviors in Olfactory Bulbectomized Mice
- (2017) Yasushi Yabuki et al. PHARMACOLOGY
- The Role of Mitochondrial Dysfunction in the Progression of Alzheimer’s Disease
- (2017) Claus Desler et al. CURRENT MEDICINAL CHEMISTRY
- The Cellular Phase of Alzheimer’s Disease
- (2016) Bart De Strooper et al. CELL
- Age and Alzheimer’s disease gene expression profiles reversed by the glutamate modulator riluzole
- (2016) A C Pereira et al. MOLECULAR PSYCHIATRY
- Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders
- (2016) Md. Torequl Islam NEUROLOGICAL RESEARCH
- Nanoemulsions for Intranasal Delivery of Riluzole to Improve Brain Bioavailability: Formulation Development and Pharmacokinetic Studies
- (2016) Rajesh H. Parikh et al. Current Drug Delivery
- Brain and Plasma Riluzole Pharmacokinetics: Effect of Minocycline Combination
- (2016) Aline Milane et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Riluzole rescues glutamate alterations, cognitive deficits, and tau pathology associated with P301L tau expression
- (2015) Holly C. Hunsberger et al. JOURNAL OF NEUROCHEMISTRY
- The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology of Alzheimer’s Disease
- (2015) Carolyn C. Rudy et al. Aging and Disease
- Riluzole prevents soluble Aβ1–42oligomers-induced perturbation of spontaneous discharge in the hippocampal CA1 region of rats
- (2014) Shuan-Cheng Ren et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Neuronal activity regulates extracellular tau in vivo
- (2014) Kaoru Yamada et al. JOURNAL OF EXPERIMENTAL MEDICINE
- P301L tau expression affects glutamate release and clearance in the hippocampal trisynaptic pathway
- (2014) Holly C. Hunsberger et al. JOURNAL OF NEUROCHEMISTRY
- Glutamatergic regulation prevents hippocampal-dependent age-related cognitive decline through dendritic spine clustering
- (2014) Ana C. Pereira et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acetylation: a new key to unlock tau’s role in neurodegeneration
- (2014) Casey Cook et al. Alzheimers Research & Therapy
- Physiological release of endogenous tau is stimulated by neuronal activity
- (2013) Amy M Pooler et al. EMBO REPORTS
- Delayed Post-Injury Administration of Riluzole Is Neuroprotective in a Preclinical Rodent Model of Cervical Spinal Cord Injury
- (2013) Yongchao Wu et al. JOURNAL OF NEUROTRAUMA
- A Prospective, Multicenter, Phase I Matched-Comparison Group Trial of Safety, Pharmacokinetics, and Preliminary Efficacy of Riluzole in Patients with Traumatic Spinal Cord Injury
- (2013) Robert G. Grossman et al. JOURNAL OF NEUROTRAUMA
- Metabotropic NMDA receptor function is required for -amyloid-induced synaptic depression
- (2013) H. W. Kessels et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Biochemistry and Cell Biology of Tau Protein in Neurofibrillary Degeneration
- (2013) E.-M. Mandelkow et al. Cold Spring Harbor Perspectives in Medicine
- Rationale for combining glutamatergic and cholinergic approaches in the symptomatic treatment of Alzheimer’s disease
- (2012) Paul T Francis et al. Expert Review of Neurotherapeutics
- Glutamate transporter EAAT2: a new target for the treatment of neurodegenerative diseases
- (2012) Chien-Liang Glenn Lin et al. Future Medicinal Chemistry
- Riluzole
- (2012) Alessandra Cifra et al. NEUROSCIENTIST
- Trans-Synaptic Spread of Tau Pathology In Vivo
- (2012) Li Liu et al. PLoS One
- Activity-Dependent Clustering of Functional Synaptic Inputs on Developing Hippocampal Dendrites
- (2011) Thomas Kleindienst et al. NEURON
- Riluzole, Neuroprotection and Amyotrophic Lateral Sclerosis
- (2010) B.C. Cheah et al. CURRENT MEDICINAL CHEMISTRY
- Antinociceptive Effect of Riluzole in Rats with Neuropathic Spinal Cord Injury Pain
- (2010) Aldric Hama et al. JOURNAL OF NEUROTRAUMA
- Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
- (2010) Giles E. Hardingham et al. NATURE REVIEWS NEUROSCIENCE
- Riluzole in cerebellar ataxia: A randomized, double-blind, placebo-controlled pilot trial
- (2010) G. Ristori et al. NEUROLOGY
- Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution
- (2009) Maria Luisa Bondì et al. Nanomedicine
- Synaptic clustering by dendritic signalling mechanisms
- (2008) Matthew E Larkum et al. CURRENT OPINION IN NEUROBIOLOGY
- Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole
- (2008) M Banasr et al. MOLECULAR PSYCHIATRY
- LTP Promotes a Selective Long-Term Stabilization and Clustering of Dendritic Spines
- (2008) Mathias De Roo et al. PLOS BIOLOGY
- Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1
- (2007) Elena Fumagalli et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More